Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: A systematic review and biomarker database integration

Fertility and Sterility

Volumn 98, Issue 6, 2012, Pages

  Galazis, Nicolas ^a   Olaleye, Olalekan ^a   Haoula, Zeina ^a   Layfield, Robert ^a   Atiomo, William ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

ovarian cancer; ovary; Polycystic; proteomics

Indexed keywords

BIOLOGICAL MARKER; CALRETICULIN; FIBRINOGEN; FIBRINOGEN GAMMA; GLUCOSE REGULATED PROTEIN 78; HEAT SHOCK PROTEIN 27; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; LAMIN; LAMIN B2; MALATE DEHYDROGENASE; PROHIBITIN; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE A; PROTEOME; SERUM ALBUMIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VIMENTIN;

CANCER RISK; CANCER TISSUE; CASE CONTROL STUDY; GENE OVEREXPRESSION; HUMAN; OVARY CANCER; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SYSTEMATIC REVIEW;

EID: 84870365971     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.08.002     Document Type: Article

References (60)

1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
2. R.A. Wild Long term health consequences of PCOS Human Reprod Update 8 2002 231 241 (Pubitemid 34618942)
3. A. Dunaif, and A. Thomas Current concepts in the polycystic ovary syndrome Annu Rev Med 52 2001 401 419 (Pubitemid 32195332)
4. E.J. Fearnley, L. Marquart, A.B. Spurdle, P. Weinstein, P.M. Webb Australian Ovarian Cancer Study Group and Australian National Endometrial Cancer Study Group Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study Cancer Causes Control 21 2010 2303 2308
5. B.G. Chittenden, G. Fullerton, A. Maheshwari, and S. Bhattacharya Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review Reprod Biomed Online 19 2009 398 405
6. O.C. Pillay, L.F. Te Fong, J.C. Crow, E. Benjamin, T. Mould, and W. Atiomo The association between polycystic ovaries and endometrial cancer Hum Reprod 21 2006 924 929
7. P. Hardiman, O.S. Pillay, and W. Atiomo Polycystic ovary syndrome and endometrial carcinoma Lancet 361 2003 1810 1812 (Pubitemid 36638434)
8. J.M. Schildkraut, P.J. Schwingl, E. Bastos, A. Evanoff, and C. Hughes Epithelial ovarian cancer risk among women with polycystic ovary syndrome Obstet Gynecol 88 1996 554 559 (Pubitemid 26326017)
9. M.A. Rossing, J.R. Daling, N.S. Weiss, D.E. Moore, and S.G. Self Ovarian tumors in a cohort of infertile women N Engl J Med 22 1994 771 776 (Pubitemid 24284766)
10. B.G. Chittenden, G. Fullerton, A. Maheshwari, and S. Bhattacharya Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review Reprod Biomed Online 19 2009 398 405
11. P.M. Spritzer, D.M. Morsch, and D. Wiltgen Polycystic ovary syndrome associated neoplasms Arq Bras Endocrinol Metabol 49 2005 805 810
12. B.T. Hennessy, R.L. Coleman, and M. Markman Ovarian cancer Lancet 17 2009 1371 1382
13. N.L. Anderson, and N.G. Anderson Proteome and proteomics: new technologies, new concepts, and new words Electrophoresis 11 1998 1853 1861 (Pubitemid 28392230)
14. W.U. Atiomo, S. Khalid, A. Ziauddin, D. Tooth, and R. Layfield Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome. Special report Expert Rev Proteomics 6 2009 469 499
15. L.A. Parker, N. Gómez Saez, B. Lumbreras, M. Porta, and I. Hernández-Aguado Methodological deficits in diagnostic research using '-omics' technologies: evaluation of the QUADOMICS tool and quality of recently published studies PLoS One 5 2010 11419
16. D.H. Choi, W.S. Lee, M. Won, M. Park, H.O. Park, and E. Kim The apolipoprotein A-I level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis J Proteome Res 9 2010 4329 4336
17. M. Insenser, M.A. Martinez-Garcia, R. Montes, J.L. San-Millán, and H.F. Escobar-Morreale Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation J Clin Endocrinol Metab 95 2010 3863 3870
18. S. Misiti, A. Stigliano, M. Borro, G. Gentile, S. Michienzi, and L. Cerquetti Proteomic profiles in hyperandrogenic syndromes J Endocrinol Invest 33 2010 156 164
19. W. Atiomo, S. Khalid, Houda M. Parameshweran, and R. Layfield Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: a systematic review BJOG 116 2009 137 143
20. I. Santillan, S. Neubeck, and U.R. Markert Comparative proteomic analysis of follicular fluids from patients with different infertility etiologies Am J Reprod Immunol 63 Suppl S1 2010 52 53
21. M. Webber, S. Neubeck, I. Hoppe, and U.R. Markert Comparative proteomic analysis of follicular fluids from patients with different infertility etiologies J Reprod Immunol 86 2010 56 57
22. M.C. Cox, M. Borro, G. Gentile, M.S. Torre, L. Aimati, and C. Tatarelli Specific effects exerted by B-lymphoproliferative diseases on peripheral T lymphocytes protein expression Haematologica 95 2010 176 177
23. K.H. Baek, Y.S. Kim, B.H. Gu, M.S. Kim, H.Y. Chung, and B.C. Choi Apolipoprotein as a novel gene associated with polycystic ovary syndrome Fertil Steril 94 2010 197 198
24. J. Ling, K.K. Zhao, Y.G. Cui, Y. Li, X. Wang, and M. Li Heat shock protein 10 regulated apoptosis of mouse ovarian granulosa cells Gynecol Endocrinol 27 2011 63 71
25. B. Peral, E. Camafeita, and J.M. Fernandez-Real Tackling the human adipose tissue proteome to gain insight into obesity and related pathologies Expert Rev Proteomics 6 2009 353 361
26. K. Hojlund, M. Mogensen, and K. Sahlin Mitochondrial dysfunction in type 2 diabetes and obesity Endocrinol Metab Clin North Am 37 2008 713
27. K.L. Abbott, J.M. Lim, L. Wells, B.B. Benigno, J.F. McDonald, and M. Pierce Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis Proteomics 10 2010 470 481
28. S. Bengtsson, M. Krogh, C.A. Szigyarto, M. Uhlen, K. Schedvins, and C. Silfverswärd Large scale proteomics analysis of human ovarian cancer for biomarkers J Proteome Res 6 2007 1440 1450 (Pubitemid 46724042)
29. R. Lemaire, S.A. Menguellet, J. Stauber, V. Marchaudon, J.P. Lucot, and P. Collinet Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Regalpha fragment, is a new potential ovary cancer biomarker J Proteome Res 6 2007 4127 4134 (Pubitemid 350158491)
30. Li XQ, Zhang SL, Cai Z, Zhou Y, Ye TM, Chiu JF. Proteomic identification of tumor-associated protein in ovarian serous cystadenocarinoma. Cancer Lett 2009;275:109-16.
31. H.J. An, D.S. Kim, Y.K. Park, S.K. Kim, Y.P. Choi, and S. Kang Comparative proteomics of ovarian epithelial tumors J Proteome Res 5 2006 1082 1090 (Pubitemid 43727786)
32. R. Lim, M. Lappas, N. Ahmed, M. Permezel, M.A. Quinn, and G.E. Rice 2D PAGE of ovarian cancer: analysis of soluble and insoluble fractions using medium-range immobilized pH gradients Biochem Biophys Res Commun 406 2011 408 413
33. M. Michalak, R.E. Milner, K. Burns, and M. Opas Calreticulin Biochem J 285 1992 681 692
34. M.G. Coppolino, and S. Dedhar Calreticulin Int J Biochem Cell Biol 30 1998 553 558 (Pubitemid 28302732)
35. R.R. Ramos, A.J. Swanson, and J. Bass Calreticulin and Hsp90 stabilize the human insulin receptor and promote its mobility in the endoplasmic reticulum Proc Natl Acad Sci USA 104 2007 10470 10475 (Pubitemid 47185689)
36. G. Boden, X. Duan, C. Homko, E.J. Molina, W. Song, and O. Perez Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals Diabetes 57 2008 2438 2444
37. S. Polterauer, C. Grimm, V. Seebacher, N. Concin, C. Marth, and C. Tomovski Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study Oncologist 14 2009 979 985
38. X. Ma, L. Fan, Y. Meng, Z. Hou, Y.D. Mao, and W. Wang Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome Mol Hum Reprod 13 2007 527 535 (Pubitemid 47241906)
39. M.E. Schinina, D. Barra, F. Bossa, L. Calabrese, L. Montesano, and M.T. Carrì Primary structure from amino acid and cDNA sequences of two Cu Zn superoxide dismutase variants from Xenopus laevis Arch Biochem 272 1989 507 515
40. Y. Hu, D.G. Rosen, Y. Zhou, L. Feng, G. Yang, and J. Liu Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress J Biol Chem 25 2005 39485 39492 (Pubitemid 41713906)
41. M. Borro, G. Gentile, A. Stigliano, S. Misiti, V. Toscano, and M. Simmaco Proteomic analysis of peripheral T lymphocytes, suitable circulating biosensors of strictly related diseases Clin Exp Immunol 150 2007 494 501 (Pubitemid 350098726)
42. T. Katsumoto, A. Mitsushima, and T. Kurimura The role of the vimentin intermediate filaments in rat 3Y1 cells elucidated by immunoelectron microscopy and computer-graphic reconstruction Biol Cell 68 1990 139 146 (Pubitemid 20139587)
43. M. Leader, M. Collins, J. Patel, and K. Henry Vimentin: an evaluation of its role as a tumour marker Histopathology 11 1987 63 72 (Pubitemid 17024336)
44. R. Timpl, and J.C. Brown The laminins Matrix Biol 14 1994 275 281 (Pubitemid 24269073)
45. S. Bandebuche, and R. Melinkeri Oxidative stress and antioxidant status in patients of ovarian cancer Biomed Res (India) 22 2011 193 197
46. A. Caglayan, B. Giray, F. Hlncal, D.C. Katlan, B. Sayal, and M.C. Salman Assessment of superoxide dismutases in tissue and blood samples of primary epithelial ovarian cancer patients Toxicol Lett 2010 196S 197S
47. A.B. Dalan, A. Ergen, H. Yilmaz, A. Karateke, and T. Isbir Manganese superoxide dismutase gene polymorphism, MnSOD plasma levels and risk of epithelial ovarian cancer J Obstet Gynaecol Res 34 2008 878 884
48. K. Senthil, S. Aranganathan, and N. Nalini Evidence of oxidative stress in the circulation of ovarian cancer patients Clin Chim Acta 339 2004 27 32 (Pubitemid 37542454)
49. T. Nishida, T. Sugiyama, A. Kataoka, M. Tashiro, M. Yakushiji, and M. Ishikawa Serum manganese superoxide dismutase (MnSOD) and histological virulence of ovarian cancer Asia Oceania J Obstet Gynaecol 19 1993 427 431 (Pubitemid 24038755)
50. J.T. Dudley, and A.J. Butte Identification of discriminating biomarkers for human disease using integrative network biology Pac Symp Biocomput 14 2009 27 38
51. M. Hudecova, J. Holte, M. Olovsson, A. Larsson, C. Berne, and I.S. Poromaa Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome - a long term follow-up Hum Reprod 26 2011 1462 1468
52. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 2004 19 25
53. A. Balen Polycystic ovary syndrome and cancer Hum Reprod Update 7 2001 522 525 (Pubitemid 33069609)
54. R.A. Wild Long-term health consequences of PCOS Hum Reprod Update 8 2002 231 241 (Pubitemid 34618942)
55. S. Wild, T. Pierpoint, H. Jacobs, and P. McKeigue Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study Hum Fertil (Camb) 3 2000 101 105
56. S. Wild, T. Pierpoint, P. McKeigue, and H. Jacobs Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study Clin Endocrinol (Oxf) 52 2000 595 600 (Pubitemid 30337085)
57. A. Daniilidis, and K. Dinas Long term health consequences of polycystic ovarian syndrome: a review analysis Hippokratia 13 2009 90 92
58. R. Pasquali, E. Stener-Victorin, B.O. Yildiz, A.J. Duleba, K. Hoeger, and H. Mason PCOS Forum: research in polycystic ovary syndrome today and Tomorrow Clin Endocrinol (Oxf) 74 2011 424 433
59. R.S. Legro A twenty-first century research agenda for polycystic ovary syndrome Best Pract Res Clin Endocrinol Metab 20 2006 331 336 (Pubitemid 43842924)
60. K. Toulis, D. Goulis, G. Mintziori, E. Kintiraki, E. Eukarpidis, and S. Mouratoglou Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome Hum Reprod Update 17 2011 741 760